Anti-beta Amyloid 37-42抗体- BSA and Azide free (ab34376)
Key features and details
- Rabbit polyclonal to beta Amyloid 37-42 - BSA and Azide free
- Suitable for: ELISA
- Reacts with: Human
- Isotype: IgG
选择批间可重复性更高的重组抗体
- 研究可靠 —— 各批次间结果一致且可重复
- 长期批量供应 —— 采用重组技术,可实现快速生产
- 首次实验即可成功 —— 经过大量验证确认了特异性
- 符合伦理标准 —— 产品不含动物成分
概述
-
产品名称
Anti-beta Amyloid 37-42抗体- BSA and Azide free -
描述
兔多克隆抗体to beta Amyloid 37-42 - BSA and Azide free -
宿主
Rabbit -
经测试应用
适用于: ELISAmore details -
种属反应性
与反应: Human -
免疫原
Synthetic peptide corresponding to beta Amyloid 37-42 (C terminal).
-
常规说明
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. -
存储溶液
Constituent: PBS -
无载体
是 -
Concentration information loading...
-
纯度
Immunogen affinity purified -
克隆
多克隆 -
同种型
IgG -
研究领域
相关产品
-
Compatible Secondaries
-
Isotype control
-
Related Products
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab34376于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
ELISA |
Use at an assay dependent concentration.
|
说明 |
---|
ELISA
Use at an assay dependent concentration. |
数据表及文件
-
Datasheet download
文献 (11)
ab34376 被引用在 11 文献中.
- Hou YC et al. The Role of Plasma Neurofilament Light Protein for Assessing Cognitive Impairment in Patients With End-Stage Renal Disease. Front Aging Neurosci 13:657794 (2021). PubMed: 34122041
- Tanaka T et al. Head-to-head comparison of amplified plasmonic exosome Aβ42 platform and single-molecule array immunoassay in a memory clinic cohort. Eur J Neurol 28:1479-1489 (2021). PubMed: 33370497
- Chiu MJ et al. Synergistic Association between Plasma Aβ1-42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia. ACS Chem Neurosci 12:1376-1383 (2021). PubMed: 33825443
- Chen TB et al. Prediction of Cerebral Amyloid Pathology Based on Plasma Amyloid and Tau Related Markers. Front Neurol 12:619388 (2021). PubMed: 34671305
- Pannee J et al. The global Alzheimer's Association round robin study on plasma amyloid β methods. Alzheimers Dement (Amst) 13:e12242 (2021). PubMed: 34692980